Across TCGA pan-cancer cohorts, RN7SKP9 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SKP9’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RN7SKP9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SKP9 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

LUSC, HNSC, and THCA are the cancer types where RN7SKP9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SKP9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.118	.007	4	view →
HNSC	Male	All	+0.114	.020	3	view →
THCA	Male	All	−0.211	.015	2	view →
BLCA	Female	III,IV	+0.284	.019	1	view →
COAD	All	II,III,IV	+0.125	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RN7SKP9 RNA expression & survival · all RN7SKP9 data types